PHARMACEUTICAL COMPOSITION COMPRISING GENISTEIN FOR TREATING NK/T CELL LYMPHOMA BY INDUCING ABNORMAL MITOCHONDRIA AND LOSS OF BCL-XL PROTEIN IN NK/TT-CELL LYMPHOMA CELL LINE, HANK-1

摘要

PURPOSE: Provided is a pharmaceutical composition comprising, as active ingredient, genistein for treating NK/T cell lymphoma by inducing abnormal mitochondria and loss of Bcl-xL protein in NK/T-cell lymphoma cell line, Hank-1. Therefore, the composition is used for remedies, processed food products, functional foods and alcoholic beverages to treat NK/T cell lymphoma. CONSTITUTION: The pharmaceutical composition for treating NK/T cell lymphoma is characterized by comprising, as active ingredient, genistein with a pharmaceutically acceptable carrier. The composition induces apoptosis and then treats NK/T cell lymphoma. The effective amount of the genistein is 10-100mg/kg/day. The health food containing the genistein induces apoptosis to prevent NK/T cell lymphoma.